Value stocks are getting crushed again by bad Covid news in a fresh blow to their long-suffering fans in the quant community.
With governments re-introducing restrictions in the face of the omicron variant, the case for buying cheap companies typically tied to the business cycle is faltering on risk aversion and the deteriorating economic outlook.
